Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17654
Country/Region: Uganda
Year: 2017
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $11,521,435 Additional Pipeline Funding: $3,500,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $2,475,445
Care: TB/HIV (HVTB) $588,424
Care: Pediatric Care and Support (PDCS) $225,248
Laboratory Infrastructure (HLAB) $33,245
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $815,511
Testing: HIV Testing and Counseling (HVCT) $1,180,477
Sexual Prevention: Other Sexual Prevention (HVOP) $109,956
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $619,232
Treatment: Adult Treatment (HTXS) $5,320,022
Treatment: Pediatric Treatment (PDTX) $153,875
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 160
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 119
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 308
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 220
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 1,081
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 770
GEND_GBV Number of people receiving post-GBV care 2018 1,549
GEND_GBV Number of people receiving post-GBV care 2018 1,109
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 223,233
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 466,305
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2018 269
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2018 2,834
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2018 443
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2018 486
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 50
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2018 2
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 221
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 46
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 1,323
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 994
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2018 110
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 105
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 134
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2018 400
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 268
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 668
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative 2018 250
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 668
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2018 129
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2018 129
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 25,888
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 17,193
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 30,181
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 20,048
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 25,888
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 17,193
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 4,317
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 2,868
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 516
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 69
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 5,311
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 2,617
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 50
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 947
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 424
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 817
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 72
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 225
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 5
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 50
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 444
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 724
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 124
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 219
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 2,492
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 4,316
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 1,915
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 3,323
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 203
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 425
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 200
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 413
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 150
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 953
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 5,170
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 9,754
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 120
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 1,729
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 792
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 1,493
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 857
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 3,022
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 79
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 610
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 4,762
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 9,763
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 1,423
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 2,791
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 29,216
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 59,785
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 22,604
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 45,117
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 2,430
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 5,909
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 2,417
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 5,554
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 3
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 670
HTS_TST Service Delivery Point (Facility) Other PITC: <1, Negative 2018 194
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 5,191
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 9,700
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 122
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 1,721
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 790
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 1,493
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 627
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 2,065
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 52
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 443
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 3,515
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 6,763
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 985
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 2,055
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 22,121
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 44,335
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 16,521
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 30,972
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 1,587
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 4,375
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 1,539
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 3,830
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 3,160
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 7,591
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 54
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 3
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 455
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 96
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 65
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 9
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 32
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 166
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 286
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 82
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 179
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 9
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 10
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 5,972
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 19,971
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 6,959
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 23,287
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 5,972
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 19,971
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 995
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 3,330
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 933
HTS_TST Sum of Test Result disaggregates 2018 10,727
HTS_TST Sum of Test Result disaggregates 2018 22,037
HTS_TST_POS By Test Result: Positive 2018 10,727
HTS_TST_POS By Test Result: Positive 2018 22,037
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2018 41
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 109
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 824
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 554
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2018 45
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2018 44
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2018 40
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2018 26
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2018 80
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Female, Positive 2018 54
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive 2018 76
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 752
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 534
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 862
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 602
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 752
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 534
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 127
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 78
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 68
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 39
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 128
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 250
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 401
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 68
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 118
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 1,407
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 2,455
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 1,078
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 1,865
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 113
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 236
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 227
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 114
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 50
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 122
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 19
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 42
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 147
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 244
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 467
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 120
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 1,326
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 2,607
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 1,019
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 2,045
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 125
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 252
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 121
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 249
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 60
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 116
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 29
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 100
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 182
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 326
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 49
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 96
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 1,091
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 2,064
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 807
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 1,516
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 84
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 195
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 82
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 183
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 40
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 81
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 87
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 130
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 64
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 44
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 154
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 128
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 410
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 141
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 481
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 35
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 5,502
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 54
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 36
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 15
KP_PREV By key population type: Transgender who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 14
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 5,621
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,723
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,940
PMTCT_ART New on ART 2018 2,271
PMTCT_ART New on ART 2018 2,442
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 4,994
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 5,382
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 71,476
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 83,876
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 4,043
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 4,389
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,203
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,349
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,674
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,899
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 45
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 38
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 121
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 103
PMTCT_STAT By Age (Numerator): : 15-19 2018 13,585
PMTCT_STAT By Age (Numerator): 10-14 2018 717
PMTCT_STAT By Age (Numerator): 10-14 2018 840
PMTCT_STAT By Age (Numerator): 15-19 2018 15,939
PMTCT_STAT By Age (Numerator): 20-24 2018 13,585
PMTCT_STAT By Age (Numerator): 20-24 2018 15,939
PMTCT_STAT By Age (Numerator): 25-49 2018 43,589
PMTCT_STAT By Age (Numerator): 25-49 2018 51,158
PMTCT_STAT By known positives: 10-14 2018 11
PMTCT_STAT By known positives: 15-19 2018 600
PMTCT_STAT By known positives: 20-24 2018 1,057
PMTCT_STAT By known positives: 25-49 2018 1,457
PMTCT_STAT By new negatives: 10-14 2018 700
PMTCT_STAT By new negatives: 15-19 2018 12,577
PMTCT_STAT By new negatives: 20-24 2018 11,804
PMTCT_STAT By new negatives: 25-49 2018 41,126
PMTCT_STAT By new positives: 10-14 2018 6
PMTCT_STAT By new positives: 15-19 2018 408
PMTCT_STAT By new positives: 20-24 2018 724
PMTCT_STAT By new positives: 25-49 2018 1,006
PMTCT_STAT By Number of known positives: 10-14 2018 26
PMTCT_STAT By Number of known positives: 15-19 2018 670
PMTCT_STAT By Number of known positives: 20-24 2018 1,192
PMTCT_STAT By Number of known positives: 25-49 2018 1,619
PMTCT_STAT By Number of new negative: 10-14 2018 803
PMTCT_STAT By Number of new negative: 15-19 2018 14,862
PMTCT_STAT By Number of new negative: 20-24 2018 14,015
PMTCT_STAT By Number of new negative: 25-49 2018 48,542
PMTCT_STAT By Number of new positives: 10-14 2018 9
PMTCT_STAT By Number of new positives: 15-19 2018 406
PMTCT_STAT By Number of new positives: 20-24 2018 731
PMTCT_STAT By Number of new positives: 25-49 2018 1,001
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 71,476
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 83,876
PMTCT_STAT_den By Age (Denominator): <15-19 2018 15,939
PMTCT_STAT_den By Age (Denominator): 10-14 2018 717
PMTCT_STAT_den By Age (Denominator): 10-14 2018 840
PMTCT_STAT_den By Age (Denominator): 15-19 2018 13,585
PMTCT_STAT_den By Age (Denominator): 20-24 2018 13,585
PMTCT_STAT_den By Age (Denominator): 20-24 2018 15,939
PMTCT_STAT_den By Age (Denominator): 25-49 2018 43,589
PMTCT_STAT_den By Age (Denominator): 25-49 2018 51,158
PP_PREV Age/sex: 10-14 Female 2018 232
PP_PREV Age/sex: 10-14 Male 2018 168
PP_PREV Age/sex: 15-19 Female 2018 98
PP_PREV Age/sex: 15-19 Male 2018 68
PP_PREV Age/sex: 20-24 Female 2018 61
PP_PREV Age/sex: 20-24 Male 2018 62
PP_PREV Age/sex: 25-49 Female 2018 226
PP_PREV Age/sex: 25-49 Male 2018 261
PP_PREV Age/sex: 50+ Female 2018 11
PP_PREV Age/sex: 50+ Male 2018 14
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 1,201
PP_PREV Sum of Age/Sex disaggregates 2018 1,201
PrEP_NEW Female 15-19 2018 314
PrEP_NEW Female 20-24 2018 314
PrEP_NEW Female 25-49 2018 314
PrEP_NEW Female 50+ 2018 306
PrEP_NEW FSW 2018 227
PrEP_NEW Male 15-19 2018 314
PrEP_NEW Male 20-24 2018 314
PrEP_NEW Male 25-49 2018 314
PrEP_NEW Male 50+ 2018 314
PrEP_NEW MSM 2018 9
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2018 2,504
PrEP_NEW TG 2018 3
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 11
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 47
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 211
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 583
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 17
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 62
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 432
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,072
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 703
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,860
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 671
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,764
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 12
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 49
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 223
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 619
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 18
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 67
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 450
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,125
TB_PREV By Age/Sex (Numerator): <15, Female 2018 11
TB_PREV By Age/Sex (Numerator): <15, Female 2018 200
TB_PREV By Age/Sex (Numerator): <15, Male 2018 10
TB_PREV By Age/Sex (Numerator): <15, Male 2018 176
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 875
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 7,024
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 588
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 4,804
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 1,484
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 12,204
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 1,484
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 12,204
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 2,980
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 24,414
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 61
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 444
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 32
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 365
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 1,744
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 14,055
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,143
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 9,550
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 2,980
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 24,414
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 30
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 128
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 487
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,495
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 48
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 173
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 901
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,730
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,466
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 4,526
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,466
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 4,526
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 30
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 128
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 487
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,495
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 48
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 173
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 901
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,730
TX_CURR Age/Sex: <1 2018 34
TX_CURR Age/Sex: <1 2018 314
TX_CURR Age/Sex: <1-9 2018 4,903
TX_CURR Age/Sex: 1-9 2018 711
TX_CURR Age/Sex: 10-14 Female 2018 228
TX_CURR Age/Sex: 10-14 Female 2018 1,581
TX_CURR Age/Sex: 10-14 Male 2018 174
TX_CURR Age/Sex: 10-14 Male 2018 1,114
TX_CURR Age/Sex: 15-19 Female 2018 407
TX_CURR Age/Sex: 15-19 Female 2018 3,040
TX_CURR Age/Sex: 15-19 Male 2018 81
TX_CURR Age/Sex: 15-19 Male 2018 632
TX_CURR Age/Sex: 20-24 Female 2018 1,325
TX_CURR Age/Sex: 20-24 Female 2018 9,616
TX_CURR Age/Sex: 20-24 Male 2018 385
TX_CURR Age/Sex: 20-24 Male 2018 2,698
TX_CURR Age/Sex: 25-49 Female 2018 7,210
TX_CURR Age/Sex: 25-49 Female 2018 55,114
TX_CURR Age/Sex: 25-49 Male 2018 4,117
TX_CURR Age/Sex: 25-49 Male 2018 31,724
TX_CURR Age/Sex: 50+ Female 2018 716
TX_CURR Age/Sex: 50+ Female 2018 5,452
TX_CURR Age/Sex: 50+ Male 2018 503
TX_CURR Age/Sex: 50+ Male 2018 3,923
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 15,891
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 120,111
TX_CURR Sum of age/sex disaggregates 2018 3,672
TX_CURR Sum of Age/Sex disaggregations 2018 488
TX_NEW Breastfeeding status 2018 2
TX_NEW Breastfeeding status 2018 78
TX_NEW By Age/Sex: <1 2018 32
TX_NEW By Age/Sex: <1 2018 274
TX_NEW By Age/Sex: 1-9 2018 43
TX_NEW By Age/Sex: 1-9 2018 457
TX_NEW By Age/Sex: 10-14 Female 2018 5
TX_NEW By Age/Sex: 10-14 Female 2018 89
TX_NEW By Age/Sex: 10-14 Male 2018 9
TX_NEW By Age/Sex: 10-14 Male 2018 69
TX_NEW By Age/Sex: 15-19 Female 2018 69
TX_NEW By Age/Sex: 15-19 Female 2018 616
TX_NEW By Age/Sex: 15-19 Male 2018 10
TX_NEW By Age/Sex: 15-19 Male 2018 134
TX_NEW By Age/Sex: 20-24 Female 2018 288
TX_NEW By Age/Sex: 20-24 Female 2018 1,954
TX_NEW By Age/Sex: 20-24 Male 2018 76
TX_NEW By Age/Sex: 20-24 Male 2018 605
TX_NEW By Age/Sex: 25-49 Female 2018 1,436
TX_NEW By Age/Sex: 25-49 Female 2018 11,865
TX_NEW By Age/Sex: 25-49 Male 2018 1,073
TX_NEW By Age/Sex: 25-49 Male 2018 8,797
TX_NEW By Age/Sex: 50+ Female 2018 133
TX_NEW By Age/Sex: 50+ Female 2018 1,172
TX_NEW By Age/Sex: 50+ Male 2018 127
TX_NEW By Age/Sex: 50+ Male 2018 1,085
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,301
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 27,117
TX_NEW Pregnancy status 2018 840
TX_NEW Pregnancy status 2018 6,794
TX_NEW Sum of Age/Sex disaggregates 2018 3,226
TX_NEW Sum of Age/Sex disaggregates 2018 26,386
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 14,303
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 108,104
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 12,875
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 97,296
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 524
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,525
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 414
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,885
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 7,820
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 59,305
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 4,117
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 31,581
TX_PVLS Numerator: Indication: Routine 2018 12,875
TX_PVLS Numerator: Indication: Routine 2018 97,296
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 59
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 502
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 1,299
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 9,736
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 596
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,921
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 470
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 3,212
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 8,656
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 65,879
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 4,581
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 35,092
TX_PVLS_den Denominator: Indication: Routine 2018 14,303
TX_PVLS_den Denominator: Indication: Routine 2018 108,104
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 59
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 547
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 1,427
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 10,810
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 153
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 473
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 136
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 424
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,462
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 7,518
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,442
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 4,443
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 4,193
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 12,858
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 4,638
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 14,205
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 153
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 475
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 136
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 424
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,724
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 8,352
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,625
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 4,954
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 15,891
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 120,111
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 314
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 2,404
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 3
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 75
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 2
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 59
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 209
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 1,468
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 100
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 802
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 641
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 4,349
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 506
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 3,563
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 9,668
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 5,076
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 73,209
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 38,990
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 897
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 6,731
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 127
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 953
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 245
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 1,923
TX_TB_den Denominator: By Screen Result: Negative 2018 14,622
TX_TB_den Denominator: By Screen Result: Negative 2018 110,504
TX_TB_den Denominator: By Screen Result: Positive 2018 1,269
TX_TB_den Denominator: By Screen Result: Positive 2018 9,607
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 1,269
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 9,607
VMMC_CIRC By Age: 10-14 2018 9,996
VMMC_CIRC By Age: 15-19 2018 17,978
VMMC_CIRC By Age: 20-24 2018 23,967
VMMC_CIRC By Age: 25-29 2018 37,937
VMMC_CIRC By Age: 30-49 2018 5,994
VMMC_CIRC By Age: 50+ 2018 3,995
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 99,867
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 99,867
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 55,936
Cross Cutting Budget Categories and Known Amounts Total: $3,081,402
Gender: Gender Based Violence (GBV) $472,824
GBV Prevention
Implementation
Capacity building
Monitoring and Evaluation
Collection and Use of Gender-related Strategic Information
Post GBV Care
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $270,185
Changing harmful gender norms and promoting positive gender norms
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Monitoring and Evaluation
Key Populations: Sex Workers $225,834
Monitoring and evaluation of SW programs
Collection and use of strategic information on SWs and clients
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Key Populations: MSM and TG $150,556
Monitoring and evaluation of MSM/TG programs
Collection and use of strategic information
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Training of health workers and community outreach workers
Condoms: Policy, Tools, and Services $602,223
Renovation $401,515
Water $506,597
Food and Nutrition: Policy, Tools, and Service Delivery $451,668